behavior/neurological
• after 30 minutes, IL1beta-fed mice fail to exhibit decreased drinking of sweetened mild unlike similarly treated wild-type mice
• however, 90 minutes after IL1beta administration mice exhibit a normal decrease in drinking behavior
|
• FCA-treated female mice fail to develop contralateral mechanical allodynia unlike similarly treated male and wild-type mice
• however, both male nor female mice develop normal ipsilateral allodynia
• FCA-treated male mice fail to develop thermal hyperalgesia unlike similarly treated female and wild-type mice
|
• FCA-treated female mice fail to develop contralateral mechanical allodynia unlike similarly treated male and wild-type mice
• however, both male nor female mice develop normal ipsilateral allodynia
|
• FCA-treated male mice fail to develop thermal hyperalgesia unlike similarly treated female and wild-type mice
|
homeostasis/metabolism
• after 30 minutes, IL1beta-fed mice fail to exhibit decreased drinking of sweetened mild unlike similarly treated wild-type mice
• however, 90 minutes after IL1beta administration mice exhibit a normal decrease in drinking behavior
|
• SC-560-treated mice fail to exhibit a reduction in cranial blood flow unlike similarly treated wild-type mice
• superoxide dismutase-treated mice fail to exhibit an increase in blood flow caused by bradykinin and A23187 unlike in similarly treated wild-type mice
|
• mice treated with U46619 or acetylcholine exhibit increased bronchoconstriction compared with similarly treated wild-type mice
• pretreatment with naproxen, diclofenac, or ibuprofen does not increase bronchoconstriction induced by U46619 or acetylcholine unlike in similarly treated wild-type mice
|
immune system
• FCA-treated female mice exhibit reduced joint destruction and swelling compared with similarly treated male or wild-type mice
|
cardiovascular system
• resting cranial blood flow is reduced in the cerebral cortex, thalamus, hippocampus, amygdala, and hypothalamus compared to in wild-type mice
|
respiratory system
• mice treated with U46619 or acetylcholine exhibit increased bronchoconstriction compared with similarly treated wild-type mice
• pretreatment with naproxen, diclofenac, or ibuprofen does not increase bronchoconstriction induced by U46619 or acetylcholine unlike in similarly treated wild-type mice
|
skeleton
• FCA-treated female mice exhibit reduced joint destruction and swelling compared with similarly treated male or wild-type mice
|